XEDEN VET 50 MG TABLET FOR DOGS
XEDEN VET 50 MG TABLET FOR DOGS
Authorised
- Enrofloxacin
Product identification
Medicine name:
XEDEN 50MG/TAB ΔΙΣΚΙΟ
XEDEN VET 50 MG TABLET FOR DOGS
Active substance:
- Enrofloxacin
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Enrofloxacin50.00milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Withdrawal period by route of administration:
-
Oral use
-
Dog
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01MA90
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Greece
Available in:
-
Greece
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Ceva Hellas LLC
Marketing authorisation date:
Manufacturing sites for batch release:
- CEVA Santé Animale
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 19787/21-02-2014/K-0173102
Date of authorisation status change:
Reference member state:
-
France
Procedure number:
- FR/V/0186/002
Concerned member states:
-
Austria
-
Belgium
-
Czechia
-
Denmark
-
Finland
-
Germany
-
Greece
-
Hungary
-
Italy
-
Luxembourg
-
Netherlands
-
Norway
-
Poland
-
Portugal
-
Romania
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
How useful was this page?: